Skip to main navigation

Main navigation

Company Announcements
Financials
- Financial Reports
- SEC Filings
Share Information
Corporate Governance
Presentations
Analyst Coverage
Calendar
Contact IR
Email Alerts

Find a provider Contact Us

Menu

Home
Company Announcements
Financials
- Financial Reports
- SEC Filings
Share Information
Corporate Governance
Presentations
Calendar
Contact IR
Email Alerts

Financial Reports

Year

Annual Report 2019 1 MB

Q3 2019 225 KB

Q2 2019 295 KB

Q1 2019 179.8 KB

Annual Report 2018 948.3 KB

Q3 2018 275.4 KB

Q2 2018 412.3 KB

Q1 2018 432.3 KB

Annual Report 2017 1 MB

Q3 2017 466.2 KB

Pagination

Current page 1
Page 2
Next page
Last page

About Us

About Us
Board Of Directors
Careers
Investor Relations
Contact Us

Patients

Find A Provider
How Does it Work?
Our Treatments
News & Events
Knowledge Center
Reimbursement
Video Gallery
Safety Information
Disclaimer

Healthcare Professional

Healthcare Professionals
Our Treatments
Technology
Clinical Research
Video Gallery

Connect with Us

×

Disclaimer

This is BrainsWay’s global website. The global website is not intended for persons in the United States and includes information on clinical indications that were not cleared by the FDA, which are subject to further US regulatory review for safety and efficacy. BrainsWay is cleared by the FDA only for patients with MDD who failed to respond to one or more anti-depressants in the current episode, and for patients with OCD as an adjunct treatment.